William Banyai - 18 Feb 2022 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role: Senior Vice President of Advanced Development and General Manager of Data Storage, Director
Signature: /s/ William Solis, as Attorney-in-Fact for William Banyai
Issuer symbol: TWST
Transactions as of: 18 Feb 2022
Net transactions value: -$103,056
Form type: 4
Filing time: 23 Feb 2022, 17:03:40 UTC
Previous filing: 01 Feb 2022
Next filing: 05 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TWST	Common Stock	Tax liability	$35,651	-670	-0.25%	$53.21	264,353	18 Feb 2022	Direct	F1
transaction	TWST	Common Stock	Sale	$67,405	-1,280	-0.48%	$52.66	263,073	22 Feb 2022	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).
F2	The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2021.

Remarks:

Senior Vice President of Advanced Development and General Manager of Data Storage